For example, Gironella et al. have shown that miR-155 targets Tumor protein 53-induced nuclear protein 1 (TP53INP1) disrupting its anti-tumoral activity in pancreatic cancer cells [34]. The gene discussed is TP53INP1; the disease is familial pancreatic carcinoma.